Use cases
Ductal expansion organoids—not long-term 2D primary hepatocytes and not HCC cell-line spheroids.
| Use | Fit | Readout | Notes |
|---|---|---|---|
| Adult liver ductal organoid expansion / disease modeling | Recommended | Expansion, genome stability, differentiation[1] | Huch system supports long-term expansion and some genetic-disease mirroring. |
| Tox / metabolism pilots (after differentiation) | Contrast | Albumin, CYP, and related functional readouts | Expansion state is not a mature hepatocyte substitute. |
| HepG2 spheroids as “liver organoids” | Do not mix | Spheroid diameter | Cell-line spheroids are not adult ductal organoids. |
In one line
Duct-enriched liver tissue → dome → Rspo/EGF/FGF10/HGF niche → brief Y-27632 → mechanical split → CK19/EpCAM → optional hepatocyte differentiation.
Protocol overview
- Ethics + cold chain; resection or biopsy liver tissue
- Trim fat/necrosis; collagenase ± Dispase; enrich ductal epithelium
- Matrix domes; Huch-type medium (Rspo, EGF, FGF10, HGF, nicotinamide, A83-01, forskolin…)[[1]]
- Brief Y-27632; score cystic ductal growth
- Feed every 2–3 days; mechanical split by growth
- CK19 / CK7 / EpCAM; mycoplasma; albumin usually low in expansion
- Switch to differentiation conditions only when hepatocyte function is needed[[1]]
- In vivo take uses transplant SOPs